Ann Surg Oncol
- LIU J, Shi Z, Cao B, Wang Z, et al
ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal
Lymph Node Involvement in Non-small Cell Lung Cancer Patients.
Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243.
Arch Bronconeumol
- GOROSPE L, Gomez-Bermejo MA, Mirambeaux-Villalona RM
Partial Anomalous Pulmonary Venous Return Incidentally Detected at Lung Cancer
Screening With Low-dose Thoracic CT.
Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00071.
BMC Cancer
- BOUTABBA A, Missaoui F, Dlala A, Kamoun H, et al
Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in
Tunisian patients.
BMC Cancer. 2024;24:417.
- DIVAN HA, Bittoni MA, Krishna A, Carbone DP, et al
Real-world patient characteristics and treatment patterns in US patients with
advanced non-small cell lung cancer.
BMC Cancer. 2024;24:424.
- MENNECIER B, Khalifa J, Descourt R, Greillier L, et al
Real-life clinical management patterns in extensive-stage small cell lung cancer
across France: a multi-method study.
BMC Cancer. 2024;24:421.
- ZENG A, Yin Y, Xu Z, Abuduwayiti A, et al
Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with
non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease
(COPD).
BMC Cancer. 2024;24:396.
- YANG F, Zheng Y, Luo Q, Zhang S, et al
Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by
regulation of the PI3K/Akt pathway.
BMC Cancer. 2024;24:408.
- SHENG M, Sun R, Fu J, Lu G, et al
The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary
metastasis.
BMC Cancer. 2024;24:399.
Br J Cancer
- KANAHORI M, Shimada E, Matsumoto Y, Endo M, et al
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM
inhibits CD8(+) T cell infiltration.
Br J Cancer. 2024;130:1083-1095.
Cancer Epidemiol Biomarkers Prev
- ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a
Decade of SEER Medicare Health Outcomes Survey Data.
Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
Cancer Lett
- GAO GB, Chen L, Pan JF, Lei T, et al
LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce
ferroptosis in non-small cell lung cancer.
Cancer Lett. 2024 Apr 2:216826. doi: 10.1016/j.canlet.2024.216826.
- HAO Z, Xin Z, Chen Y, Shao Z, et al
JAML promotes the antitumor role of tumor-resident CD8(+) T cells by facilitating
their innate-like function in human lung cancer.
Cancer Lett. 2024 Apr 1:216839. doi: 10.1016/j.canlet.2024.216839.
Cancer Res
- LIU Y, Murazzi I, Fuller AM, Pan H, et al
Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial
Barrier and Promote Metastasis.
Cancer Res. 2024;84:977-993.
- XU Y, Deng C, Chen H, Song Y, et al
Osteosarcoma Cells Secrete CXCL14 That Activates Integrin alpha11beta1 on Fibroblasts to
Form a Lung Metastatic Niche.
Cancer Res. 2024;84:994-1012.
Clin Cancer Res
- SINGH AK, Lewis CD, Boas CAWV, Diebolder P, et al
Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed
Human scFv Library.
Clin Cancer Res. 2024;30:1293-1306.
- VAIDYA P, Cohen EEW
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging
Evidence.
Clin Cancer Res. 2024;30:1232-1239.
Clin Lung Cancer
- GEORGE B, Baydoun A, Bhat S, Bailey L, et al
Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients
Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell
Lung Cancer - Results from a Single Institution Study.
Clin Lung Cancer. 2024 Feb 24:S1525-7304(24)00030.
- MOGHANAKI D, Taylor J, Bryant AK, Vitzthum LK, et al
Lung Cancer Survival Trends in the Veterans Health Administration.
Clin Lung Cancer. 2024 Mar 2:S1525-7304(24)00035.
- KHOKHAR B, Chiang B, Iglay K, Reynolds K, et al
QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR
Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review.
Clin Lung Cancer. 2024 Feb 17:S1525-7304(24)00016.
Eur J Cardiothorac Surg
- CHARLOUX A, Olland A, Falcoz PE
Minute ventilation to carbon dioxide slope and risk stratification before lung
cancer resection.
Eur J Cardiothorac Surg. 2024 Apr 5:ezad390. doi: 10.1093.
- LAMPRIDIS S
Optimising care in obese lung cancer patients undergoing lobectomy: Analysing
complications by surgical approach.
Eur J Cardiothorac Surg. 2024 Apr 1:ezae129. doi: 10.1093.
Eur Respir J
- BRUDON A, Legendre M, Mageau A, Bermudez J, et al
High risk of lung cancer in surfactant-related gene variant carriers.
Eur Respir J. 2024 Apr 4:2301809. doi: 10.1183/13993003.01809-2023.
Int J Cancer
- SEBASTIAN M, Eberhardt WEE, von der Heyde E, Dorfel S, et al
Patient-reported outcomes in advanced NSCLC before and during the COVID-19
pandemic: Real-world data from the German prospective CRISP Registry
(AIO-TRK-0315).
Int J Cancer. 2024;154:1967-1978.
- GU Z, Huang P, Zhao J, Luo C, et al
Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR
mutations was associated with a favorable prognosis to EGFR-TKIs.
Int J Cancer. 2024;154:1979-1986.
- LIU X, Xie X, Sui C, Liu X, et al
Unraveling the cross-talk between N6-methyladenosine modification and non-coding
RNAs in breast cancer: Mechanisms and clinical implications.
Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34900.
Int J Radiat Oncol Biol Phys
- KIM KH, Kang N, Song SY, Kim HJ, et al
Safety and efficacy of HL301 in radiation pneumonitis in patients with
unresectable non-small cell lung cancer receiving curative concurrent
chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled,
phase IIa clinical trial.
Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
- HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors
influencing survival benefit in combination trials.
Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
J Cancer Res Clin Oncol
- SAKASHITA M, Motoi N, Yamamoto G, Gambe E, et al
An algorithm-based technique for counting mitochondria in cells using
immunohistochemical staining of formalin-fixed and paraffin-embedded sections.
J Cancer Res Clin Oncol. 2024;150:172.
- ZHAO R, Guan X, Zhang P, Liu Y, et al
Development of postoperative bronchopleural fistula after neoadjuvant
immunochemotherapy in non-small cell lung cancer: case reports and review of the
literature.
J Cancer Res Clin Oncol. 2024;150:175.
J Clin Invest
- TAN AC, Cook SL, Khasraw M
Soluble immune-checkpoint factors: a potential immunotherapy biomarker.
J Clin Invest. 2024;134:e179352.
- HAYASHI H, Chamoto K, Hatae R, Kurosaki T, et al
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and
response to PD-1 blockade.
J Clin Invest. 2024;134:e168318.
J Clin Oncol
- NEAL J, Pavlakis N, Kim SW, Goto Y, et al
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus
Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor
and Chemotherapy.
J Clin Oncol. 2024 Mar 29:JCO2302166. doi: 10.1200/JCO.23.02166.
- DAI W, Wang Y, Liao J, Wei X, et al
Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care
After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized,
Controlled Trial.
J Clin Oncol. 2024 Apr 4:JCO2301854. doi: 10.1200/JCO.23.01854.
J Nucl Med
- LEUNG KH, Rowe SP, Sadaghiani MS, Leal JP, et al
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor
Quantification and Prognosis of Cancer on PET/CT.
J Nucl Med. 2024 Feb 29:jnumed.123.267048. doi: 10.2967/jnumed.123.267048.
- SCHULER M, Hense J, Darwiche K, Michels S, et al
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted
Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired
Resistance.
J Nucl Med. 2024 Apr 4:jnumed.123.266979. doi: 10.2967/jnumed.123.266979.
J Thorac Oncol
- DETTERBECK FC, Ostrowski M, Hoffmann H, Rami-Porta R, et al
The IASLC Lung Cancer Staging Project: Proposals for Revision of the
Classification of Residual Tumor after Resection for the Forthcoming (9(th))
Edition of the TNM Classification of Lung Cancer.
J Thorac Oncol. 2024 Apr 1:S1556-0864(24)00129.
JAMA Oncol
- AKAMATSU H
Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung Cancer.
JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0231.
- TACHIHARA M, Tsujino K
Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung
Cancer-Reply.
JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0234.
Lancet
- MUROYA D, Morimitsu Y, Nakamura K, Hayashi K, et al
Hidden metastatic lung tumour diagnosed by AI.
Lancet. 2024;403:1290.
Lung Cancer
- PU X, Xiao Z, Li J, Wu Z, et al
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung
cancer patients who failed first-line treatment: A multicenter, randomized phase
II trial.
Lung Cancer. 2024;191:107538.
- GUDINA AT, Kamen C, Hardy SJ, Kehoe L, et al
Revisiting the lung cancer screening eligibility criteria to promote equity for
Black individuals.
Lung Cancer. 2024;191:107539.
- LYHNE CHRISTENSEN N, Gouliaev A, McPhail S, Lyratzopoulos G, et al
Lung cancer among the Elderly in Denmark - A comprehensive population-based
cohort study.
Lung Cancer. 2024;191:107555.
- GABRIEL L, McVeigh T, Macmahon S, Avila Z, et al
Familial rare EGFR-mutant lung cancer syndrome: Review of literature and
description of R776H family.
Lung Cancer. 2024;191:107543.
Lung Cancer (Auckl)
- DOU XJ, Ma RY, Ren DW, Liu Q, et al
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients
with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A
Retrospective Exploratory Study.
Lung Cancer (Auckl). 2024;15:29-40.
Mol Cancer Ther
- LULLA AR, Akli S, Karakas C, Caruso JA, et al
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis.
Mol Cancer Ther. 2024;23:492-506.
Oncogene
- HEIM TE, Hankins ML, Belayneh R, Douglas N, et al
RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase
1A1 in osteosarcoma lung metastases.
Oncogene. 2024;43:1007-1018.
- MCCLELLAN B, Wilson CN, Brenner AJ, Jolly CA, et al
Flotillin-1 palmitoylation is essential for its stability and subsequent tumor
promoting capabilities.
Oncogene. 2024;43:1063-1074.
Oncologist
- ALLENDE S, Turcott JG, Verastegui E, Rodriguez-Mayoral O, et al
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small
Cell Lung Cancer: The PACO Randomized Clinical Trial.
Oncologist. 2024 Apr 1:oyae050. doi: 10.1093.
PLoS One
- HAN H, Huang H, Chen AP, Tang Y, et al
High CASC expression predicts poor prognosis of lung cancer: A systematic review
with meta-analysis.
PLoS One. 2024;19:e0292726.
- ZHANG Y, Liu H, Chang C, Yin Y, et al
Machine learning for differentiating lung squamous cell cancer from
adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT
radiomics.
PLoS One. 2024;19:e0300170.
- LV M, Li X, Yin Z, Yang H, et al
Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic
biomarker associated with tumor immunity in non-small-cell lung cancer.
PLoS One. 2024;19:e0294227.
- LE ROUX O, Everitt JI, Counter CM
p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
PLoS One. 2024;19:e0292189.
Thorax
- SHAH PL
Ablation for lung cancer: hot or cold intervention.
Thorax. 2024 Apr 4:thorax-2023-221369. doi: 10.1136/thorax-2023-221369.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016